Research Paper Volume 15, Issue 12 pp 5569—5591

Figure 6. The immunohistochemical staining characteristics and expression levels of SP100 in PAAD patient tissues and their correlation with clinical features of PAAD patients. (A, B) The immunohistochemical staining features of SP100 in the pancreatic cancer tissue and adjacent tissue of patient ZCPA190705 were examined at 10X (a) and 40X (b) magnification, respectively; (C, D) The immunohistochemical staining features of SP100 in the pancreatic cancer tissue and adjacent tissue of patient ZCPA190713 were examined at 10X (a) and 40X (b) magnification, respectively; (E) The increased expression level of SP100 was significantly correlated with shorter OS; (F) The increased expression level of SP100 was significantly correlated with later TNM staging; (G) The increased expression level of SP100 was significantly correlated with later N staging; (H) The increased expression level of SP100 was significantly correlated with higher pathological grade; (I) The increased expression level of SP100 was significantly correlated with smoking history; (J) The increased expression level of SP100 was significantly correlated with macrovascular invasion; (K) The increased expression level of SP100 was significantly correlated with history of diabetes; (L) The increased expression level of SP100 was significantly correlated with drinking history.